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Regulation of BCR Signal Transduction
in B-1 Cells Requires the Expression
of the Src Family Kinase Lck
unique phenotype of B-1a BCR signaling is induced by
chronic encounter with antigen in specific microenviron-
ments, such as the peritoneal cavity (Chumley et al.,
2002). As a result, peritoneal B-1a cells exist in a distinc-
tive state of activation and/or differentiation. Indeed, it
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Denver, Colorado 80206 has been suggested, based on the similarities in the
downstream signaling properties and propensity for
self-Ag recognition, that B-1a cells are in an unique
“anergic” state (Wong et al., 2002). In support of thisSummary
idea, B-1a cells like anergic B cells are unresponsive to
BCR stimulation but will respond to noncognate helpAlthough found predominantly in the peritoneal and
pleural cavities, B-1 cells are also present in other such as cytokines, anti-CD40 treatment, or lipopolysac-
charides (Murakami et al., 1994; Nisitani et al., 1995).peripheral tissues such as spleen and lung. While simi-
lar in surface phenotypes, such as CD5, all B-1 cells However, the downstream mechanisms that keep these
potentially self-reactive cells refractory to further BCRare not equivalent in their response to stimuli. Here,
we report that the src family kinase Lck is required to stimulation are poorly understood.
We have recently described an immunoglobulin trans-confer the BCR hyporesponsiveness typical of CD5
B-1 cells and appears involved in the maintenance of genic mouse model (VH11V9 or 11/9) in which the
spleen and peritoneal cavity are populated with B cellstheir unique function. Splenic B-1 cells express CD5
but not Lck and are not hyporesponsive; however, displaying a characteristic B-1 cell specificity and sur-
face phenotype, including the expression of CD5 (Chum-within the peritoneum, these B-1 cells are induced to
express Lck and acquire a hyporesponsive phenotype. ley et al., 2002). Surprisingly, splenic and peritoneal
CD5 B cells from 11/9 mice exhibited distinct signalingPeritoneal B-1 cells from lck-deficient mice, while
CD5, no longer exhibit attenuated BCR signaling. In- phenotypes. Splenic 11/9 B cells display a B-2 BCR
signaling phenotype, while peritoneal 11/9 B cells ex-terestingly, lck-null mice exhibited increased natural
antibody levels characteristic of B-1 cells. Taken to- hibit the hyporesponsive B-1a phenotype (Chumley et
al., 2002). These results suggest that CD5 expressiongether, these results demonstrate a key role for Lck
in modulating the signaling and cellular fate of B-1 alone is not sufficient to confer the “B-1a” signaling
phenotype. We have taken advantage of the signalingB cells.
disparity between splenic and peritoneal 11/9 B cells to
further dissect the molecular mechanism(s) responsibleIntroduction
for hyporesponsiveness in B-1 cells. We find that the
peritoneal B-1a BCR signaling phenotype requires ex-B-1 cells are a minor but important subset of B cells in
mice and humans. They are distinguished from conven- pression of the common T cell tyrosine kinase, Lck.
Lck and CD5 levels are not necessarily coordinatelytional B-2 cells based on their surface phenotype, ana-
tomical localization, and capacity for self-renewal. In regulated, and we demonstrate that expression of Lck
in B-1 cells is an inducible phenomenon contingent onmice, B-1 cells can be found in various peripheral sites
but predominate in the pleural and peritoneal cavities the microenvironment. Further, in Lck-deficient mice,
where B-1 B cell development is reportedly normal (Uli-(Hardy and Hayakawa, 2001). B-1 cell development is
Ag driven and potentially reflects selection by both self vieri et al., 2003), peritoneal CD5 B-1 cells are no longer
hyporesponsive. Together, our data suggest that Lck isand thymus-independent exogenous Ags (Arnold et al.,
2000; Hayakawa et al., 1999). The resulting B-1 popula- a required component of the inhibitory signaling mecha-
nism which, when coexpressed with CD5, can confertion includes polyreactive as well as autoreactive B cell
specificities and produces the majority of serum IgM hyporesponsiveness in B cells.
and IgA. These “natural Abs” are essential for early host
defense against microbial and parasitic infections and Results
may serve a role in the initiation of adaptive immune
responses (Boes et al., 1998; McDaniel et al., 1984; Pa- BCR Signaling Is Impaired in Peritoneal but Not
ciorkowski et al., 2000). Splenic CD5 11/9 Tg B Cells
B-1 (specifically CD5 B-1a) cells differ from B-2 cells VH11/V9 (,) Ig transgenic (11/9) mice populate both
in their responses to external stimuli. While engagement the peritoneum and spleen with B cells expressing a
of the B cell antigen receptors (BCR) on B-2 cells leads phosphatidylcholine (PtC)-specific BCR frequently seen
to robust mobilization of intracellular calcium and prolif- in B-1 cells from wild-type mice (Carmack et al., 1990;
eration, the B-1 cell response is characterized by mod- Chumley et al., 2002). As previously reported (Chumley
est calcium mobilization, impaired proliferation, and in- et al., 2000), both splenic and peritoneal 11/9 B cells fit
creased apoptosis (Morris and Rothstein, 1993; Weiss the surface phenotype for B-1 cells (Figure 1A). Specifi-
and Littman, 1994). We have previously shown that the cally, these cells are IgM, IgDlo, B220lo, and CD23neg
and are most notably CD5 (Martin and Kearney, 2001;
Stall et al., 1996). Thus, surface phenotype alone would*Correspondence: cambierj@njc.org
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Figure 1. Splenic CD5 B Cells from 11/9 Tg
Mice Show No Sign of Attenuated Calcium
Mobilization
(A) Expression of selected markers on splenic
(dashed) or peritoneal (solid) B cells from
spleen or peritoneum of non-Tg or 11/9 mice
were compared by flow cytometry. Only B
cells are shown as delineated by size, exclu-
sion of 7AAD, and expression of CD19. Anti-
VH11 Ab (RidA) was used to show allelic ex-
clusion in 11/9 mice. The gray highlighted
populations in non-Tg mice represents the
criteria used to define peritoneal B-1a cells
in this comparison.
(B) Splenic B-2 or peritoneal B-1 cells (as
gated above) from 11/9 and non-Tg mice
were loaded with Indo-1AM, and mean intra-
cellular calcium mobilization was measured
following stimulation with anti-IgM F(ab’)2 at
1.0 g/106 cells. Data shown are representa-
tive of multiple experiments.
suggest that splenic 11/9 B cells are genuine CD5 B-1 lated BCR signaling typical of B-1a cells (Chumley et
al., 2002; Martin and Kearney, 2001).cells and would behave accordingly. However, in con-
trast to the signaling typical of B-1a cells, BCR-mediated
Lck Expression Is Associated with Increased CD5Ca2 mobilization was not impaired in 11/9 splenic B
Phosphorylation and Impaired BCR-Mediatedcells despite expression of CD5 (Figure 1B). By compari-
Ca2 Mobilization in B-1 Cellsson, peritoneal CD5 B-1 cells from 11/9 and non-Tg
To understand differences in CD5 phosphorylation, wecontrol mice demonstrated typical reduced Ca2 mobili-
examined the possibility that peritoneal B-1a cells differzation.
in the expression of certain PTKs. It has been suggestedTo explore the molecular basis of the differences in
that the src family kinase Lyn is responsible for theBCR-mediated Ca2 mobilization in splenic and perito-
phosphorylation of CD5 in B-1 cells (Ochi et al., 1999).neal CD5 B-1 cells, we examined tyrosyl phosphoryla-
However, we observed no difference in either the ex-tion following BCR aggregation. An initial examination
pression or inducible phosphorylation of Lyn in splenicof whole-cell lysates from peritoneal B-1a cells of 11/9
and peritoneal 11/9 B cells (Figure 2C). In fact, B cellsand control mice showed constitutively enhanced pro-
from 11/9 mice, as well as B-1a cells from non-Tg con-tein phosphorylation compared to splenic counterparts
trols, had increased levels of basal Lyn phosphorylation(Figure 2A). Upon BCR engagement, a discernible in-
relative to non-Tg B-2 cells. The increased Lyn phos-crease in tyrosyl phosphorylation was observed in all
phorylation in these B cells correlated with increasedpopulations. While increased basal phosphorylation, as
basal tyrosine phosphorylation compared to controlswell as CD5 expression, suggests a prior encounter with
(Figure 2A) and may be the result of the self-Ag specifici-Ag (Berland and Wortis, 1998; Wong et al., 2002), the
ties inherent in these populations. Similar to Lyn, expres-increase in BCR-mediated tyrosyl phosphorylation in
sion and phosphorylation of the src family kinases Fynperitoneal B-1a cells is a notable contrast to the atten-
and Blk did not differ between splenic and peritoneal Buation seen in traditional models of B cell anergy (Ben-
cells from 11/9 or control mice (data not shown). We
schop et al., 2001; Cooke et al., 1994).
also observed no difference between B-1 and B-2 cells
As the modulation of BCR-mediated Ca2mobilization in the induced phosphorylation of the non-src family
in B-1a cells has been shown to require CD5 expression PTK Syk following BCR stimulation (Figure 2C). In con-
and phosphorylation (Bikah et al., 1996; Gary-Gouy et trast, a comparison of Lck in splenic and peritoneal B
al., 2002), CD5 was immunoprecipitated from B cell pop- cells from 11/9 and non-Tg mice yielded an entirely
ulations and blotted for tyrosyl phosphorylation. CD5 different result. Peritoneal B-1a cells from 11/9 and non-
phosphorylation was observed in both resting and stim- Tg mice uniquely expressed and phosphorylated the
ulated peritoneal B-1a cells from 11/9 and non-Tg mice predominately T cell-associated kinase Lck (Figure 2C).
(Figure 2B). Surprisingly, splenic 11/9 B cells showed While Lck expression has been shown previously in peri-
no detectable basal CD5 phosphorylation, and BCR en- toneal CD5 B-1 cells (Majolini et al., 1998), little is un-
gagement led to only a minor increase in CD5 phosphor- derstood regarding its function.
ylation (Figure 2B). This limited phosphorylation was
observed in splenic 11/9 B cells despite CD5 expression B-1 Populations of Non-Tg Mice Vary in Expression
equivalent to peritoneal 11/9 B cells (Figures 1A and of CD5 and Lck and in BCR Responsiveness
2B). These data suggest that while CD5 may be involved, As splenic 11/9 CD5 B cells do not express Lck and
differ from their peritoneal counterparts in BCR-medi-expression alone is not sufficient to produce the modu-
Expression of Lck in B-1 Phenotype and Function
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wild-type mice (Figures 3A and 3B; Stall et al., 1996).
Figure 3C (left) shows that CD5 B-1 cells resident in the
spleen of non-Tg mice show no hyporesponsiveness,
producing a BCR-mediated Ca2 response comparable
to B-2 cells from the same spleen. Lck was readily de-
tected in splenic T cells and to a lesser degree in perito-
neal B-1 cells by intracellular FACS analysis (Figure 3D).
However, both the splenic B-2 and B-1 cells were nega-
tive for Lck. Finally, CD5 B-1b cells, which are a normal
subset of the peritoneal B-1 population in wild-type
mice, have been reported to be functionally equivalent
to B-1a cells. Thus, we devised a protocol that allowed
us to separately analyze the three distinct peritoneal B
cell populations in non-Tg mice (Figure 3B): B-1a
(CD19/CD5/CD23/CD11b), B-1b (CD19/CD5/
CD23/CD11b), and recirculating B-2 (CD19/CD5/
CD23/CD11b). BCR-mediated Ca2 mobilization was
equivalent in peritoneal CD5 B-1b compared to B-2
cells (Figure 3C, right), albeit with some differences in
response kinetics. Interestingly, Lck was detected in
B-1b cells but at lower levels than for B-1a cells (Fig-
ure 3D).
Peritoneal Microenviroment Induces Lck Expression
in Splenic 11/9 B Cells
Splenic 11/9 B cells exposed to the peritoneal microen-
vironment, either via adoptive transfer or in vitro culture,
begin to assume the hyporesponsive BCR signaling
phenotype of B-1a cells (Chumley et al., 2002). This was
shown to be the combined affect of cognate Ag (PtC)
exposure and unique microenvironment. Figure 4 shows
that within 48 hr of in vitro culture in cell-free peritoneal
lavage supernatant (PerSup), splenic 11/9 B cells have
significantly attenuated their capacity to mobilize Ca2
following BCR aggregation (Figure 4A). This was associ-
ated with a steady increase in basal phosphotyrosine
levels suggestive of Ag encounter (Figure 4B). Most in-
terestingly, the diminishing BCR-mediated Ca2 response
and increasing basal tyrosyl phosphorylation of PerSup-
cultured 11/9 splenic B cells correlated with increased
Figure 2. Lck Expression in Peritoneal B-1 Cells Correlates with expression and phosphorylation of Lck (Figure 4B). The
Phosphorylation of CD5
signaling phenotype of non-Tg splenic B cells was only
Splenic B-2 or peritoneal B-1 cells from 11/9 and non-Tg mice B minimally affected by similar culturing (Figure 4A; Chum-cells were either unstimulated or stimulated with anti-IgM F(ab’)2.
ley et al., 2002), and no expression of Lck was detectableCells were then lysed and total lysates or immunoprecipitates
(data not shown). The hyporesponsiveness of PerSup-loaded onto SDS-PAGE gels.
(A) Tyrosyl phosphorylated proteins from whole-cell lysates (WCL) cultured splenic 11/9 B cells can not be explained by
was analyzed from 2  106 cells/lane. receptor downmodulation, as expression of membrane
(B) CD5 was immunoprecipitated from lysates (30  106 cells) using IgM (mIgM) did not decrease by more than 30% of start-
purified anti-CD5 rabbit sera. ing levels (Figure 4A). In fact, expression of mIgM is(C) Src family PTKs Lyn and Lck and the non-src PTK Syk were
increasing by 48 hr, yet BCR-mediated Ca2 remainsindividually immunoprecipitated from lysates (30  106 cells) using
suppressed. These data demonstrate that the attenua-specific Abs and immunoblotted for phosphotyrosine (4G10). The
same blots were then stripped and reprobed with anti-effector Abs tion of BCR-mediated Ca2 mobilization of splenic 11/9
to determine absolute protein levels. For whole-cell lysates, blot B cells coincides with the onset of Lck expression.
was stripped and reprobed for the ubiquitous cytoplasmic protein
tubulin to control for loading quantities. Data shown are representa-
BCR Signaling Phenotype of B-1a Cells Is Conferredtive of multiple experiments.
on B-2 Cells by Coexpression of CD5 and Lck
To examine how CD5 and Lck may function to regulate
BCR signaling, we used retroviral vectors to express
these molecules in B cells. Aggregation of BCR on K46ated Ca2 mobilization, we sought to examine the
splenic B-1 population from non-Tg mice. While B cells lymphoma cells results in a robust mobilization of Ca2
typical of B-2 cells (Figure 5B). By comparison, the CH12matching the description of B-1a cells (CD19/CD43/
CD23/CD5) dominate the pleural cavities, a phenotyp- lymphoma has both the surface phenotype and signal-
ing characteristics of B-1a cells (Figures 5A and 5B),ically similar population can be found in the spleen of
Immunity
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Figure 3. Lck and CD5 Coexpression in B-1
Cells from Non-Tg Mice Is Associated with
BCR Hyporesponsiveness
(A) Splenic B-1 and B-2 cells from non-Tg
mice were isolated by gating on CD19 cells
followed by CD5 and CD23 (boxes). Splenic
B-1 populations were also confirmed to be
CD43 and CD9 (data not shown).
(B) Peritoneal B cell populations were subdi-
vided by the following gating scheme: B-1a
(CD19/CD5/CD23/CD11b), B-1b (CD19/
CD5/CD23/CD11b), and B-2 (CD19/
CD5/CD23/CD11b).
(C) Spleen and peritoneal populations corre-
sponding to those delineated in (A) and (B)
were measured for mobilization of [Ca2]i fol-
lowing BCR stimulation, as previously de-
scribed. Additionally, gated T cells (CD19/
CD5/CD43/CD23) were included as a
negative control.
(D) Similarly, the levels of Lck within these
defined populations were examined by flow
cytometry. Isotype control is shown as filled
gray line. Data shown is representative of
multiple experiments.
including the expression and phosphorylation of CD5 significantly alter the Ca2 response in these cells (Figure
5B, lower panel). Only in K46 cells coexpressing CD5and Lck (Figure 5C; Haughton et al., 1986). Therefore,
we used K46 and CH12 as prototypic B-2 and B-1 and Lck was Ca2mobilization reduced to levels compa-
rable to peritoneal CD5 B-1a cells (Figure 5B). Ourcells, respectively, for subsequent experiments. K46
cells were retrovirally infected to achieve ectopic ex- results also suggested that Lck is not uniquely required
for CD5 phosphorylation, as indicated by the responsespression of CD5 (CD5), Lck (Lck), or Lyn (Lyn). Sub-
sequent transduction of CD5 cells with Lck- or Lyn- of CD5 cells. Yet, densitometry analysis of the relative
ratio of phospho-CD5 to CD5 immunoprecipitated fromencoding virus produced the CD5/Lck and CD5/Lyn
lines. Prior to analysis, cells were sorted based on fluo- these cells indicates that more efficient CD5 phosphory-
lation occurs in the presence of Lck (a ratio of 0.95 forrescent reporter expression and equivalent surface ex-
pression of mIgM (Figure 5A). CH12 and 1.0 for CD5/Lck compared to 0.72 for CD5
at 1 min stimulation).Coexpression of CD5 and Lck resulted in attenuated
BCR-mediated calcium response in K46 cells; how- One caveat of these studies is the high expression
levels of transduced genes by retroviral promoters. Toever, CD5 expression alone caused only a modest re-
duction (Figure 5B, upper panel). BCR aggregation led examine the relative contribution of CD5 levels to the
BCR response, we sorted CD5 and CD5/Lck cells toto a comparable increase in protein tyrosyl phosphoryla-
tion in all populations examined (Figure 5C). In all cells obtain physiologically representative expression of CD5
and analyzed BCR-mediated Ca2 mobilization (Figurewith detectable surface expression of CD5, i.e., CH12,
CD5, CD5/Lyn, and CD5/Lck (Figure 5A), BCR ag- 5D, upper histogram). We observed no change in the
overall Ca2 response of these cells in relation to CD5gregation led to tyrosyl phosphorylation of CD5 (Figure
5C). Lck was readily immunoprecipitated from Lck and levels (Figure 5D, lower panels). We were unable to per-
form a similar real-time gating for Lck-expressing cellsCD5/Lck, as well as from the prototypic B-1 cell, CH12
(Figure 5C). Comparable to ex vivo B-1a cells, Lck- as expression of the fluorescent protein reporter and
Lck were not correlated. Taken together, these resultsexpressing lines demonstrated basal phospho-Lck with
little increase in these levels following stimulation. Ec- suggest that the coexpression of Lck and CD5 is re-
quired for B-1 cell hyporesponsiveness.topic expression of Lyn with CD5 (CD5/Lyn) did not
Expression of Lck in B-1 Phenotype and Function
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ported no impairment in B-1 cell development (Ulivieri
et al., 2003). We found that while Lck is not necessary
for development of peritoneal CD5 B-1 cells per se
(Figure 6A), its absence leads to alterations in the quan-
tity, signaling characteristics, and responsiveness of the
B-1 population. The percentage of CD5CD23 perito-
neal B cells was modestly enhanced in Lck-deficient
mice (Figures 6A and 6B). This difference was less ap-
parent in strains expressing the 11/9 transgene. Yet, the
absolute number of CD19 peritoneal cells was actually
lower in Lck-deficient non-Tg mice by approximately 3-
to 4-fold, and 11/9 peritoneal populations were also
reduced in the absence of Lck by 2-fold (Figure 6B).
Comparison of the individual peritoneal B cell subsets
(B-1a, B-1b, and B-2) revealed that while the proportion
of B-1a cells increased in the absence of Lck compared
to controls (32%  5% versus 50%  5%), B-1b cells
(32%  2% versus 22%  4%) and, to a lesser extent,
B-2 cells (36% 5% versus 29% 3%) were decreased
(Figure 6B). Again, mice utilizing the 11/9 transgene
demonstrated little change in subset ratios, with per-
haps a slight reduction in B-1b proportion (13%  2%
versus 8%  3%). The more modest reduction in
11/9xLck/ mice may reflect the greater starting per-
centage of CD5/CD19 peritoneal B-1a cells in 11/9
mice. Alternatively, as CD5/CD19 B cells are the pre-
dominant B cell phenotype generated in 11/9 mice, it
may represent the greater ability of 11/9xLck/ mice to
replenish the peritoneum with precursors of B-1a cells.
Our previous results show that surface phenotype
alone is not sufficient to determine B-1 cell respon-
siveness; therefore, we assessed the signaling of B-1
cells from Lck-deficient mice. Gating on peritoneal or
Figure 4. Acquisition of a Hyporesponsive Signaling Phenotype by splenic B cells by surface phenotype, we examined theSplenic 11/9 B Cells Correlates with the Expression of Lck
Ca2 response following BCR engagement. Though ap-
Splenic or peritoneal 11/9 and splenic non-Tg CD5 B cells were
pearing B-1a-like in terms of marker expression, CD5isolated and cultured in cell-free peritoneal lavage supernatant (Per-
peritoneal B cells from Lck/ mice do not exhibit anSup) for up to 48 hr.
attenuated Ca2 response (Figure 6C). BCR aggregation(A) At various times of culture, 11/9 and non-Tg splenic B cells were
recovered and loaded with Indo-1AM and stimulated with anti-IgM led to a Ca2 mobilization in these cells that was similar
F(ab’)2 to evaluate [Ca2]i mobilization. A cohort of these cells were in magnitude to the response elicited in splenic B-2 cells
analyzed for changes in surface IgM levels, and results for 11/9 from the same animals (Figure 6C). Similarly, peritoneal
cultures are shown as mean fluorescent intensity (MFI) in the legend. CD5 B-1 cells from 11/9xLck/ mice no longer dis-
(B) 11/9 splenic and peritoneal CD5 B cells were purified and cul-
played reduced BCR-mediated Ca2 responses (Figuretured in PerSup as above. At indicated times, cohorts were stimu-
6C). These results are consistent with the hypothesislated with anti-IgM F(ab’)2 and then lysed. Total cell lysates (5  106
that signaling differences between splenic and perito-cells) were resolved by SDS-PAGE and analyzed by anti-phospho-
tyrosine immunoblotting. The same blot was then stripped and re- neal CD5 B-1 cells is in part a function of the unique
probed with antisera against Lck and Syk (the latter as control for expression of Lck by peritoneal B-1 cells.
protein loading). Data shown are representative of multiple experi- Lck-deficient mice are devoid of most peripheral /
ments. T cells and significantly reduced in 	/
 T cells (Molina
et al., 1992). Directly or indirectly, the absence of T cells
may influence or alter the peritoneal microenvironment
Lack of Lck Alters Peritoneal Population Dynamics we believe necessary for acquisition of the B-1a cell
and Responsiveness of CD5 B-1 Cells signaling phenotype. Therefore, we sought to examine
Our findings point to Lck as a key modulator of BCR the B cell-autonomous effect of Lck ablation by using
signaling in B-1a cells. One logical extension of this adoptive transfer. Previously we have shown that
hypothesis is that Lck may be important for the develop- splenic 11/9 B cells transferred to peritoneal cavity will
ment and/or physiology of the B-1 cell population. To become hyporesponsive, and this phenomenon is predi-
address the role of Lck in B-1 cell development and cated on the microenvironment and availability of Ag
function, we examined the B cell populations of Lck- (Chumley et al., 2002). Figure 6D demonstrates that
deficient non-Tg and 11/9 Tg mice. Lck-deficient mice splenic 11/9 B cells transferred to the peritoneum of
have been well characterized with respect to T cell de- Lck/ mice acquire an attenuated BCR signaling re-
velopment (Molina et al., 1992), and a recent study of sponse. In contrast, splenic 11/9xLck/ B cells placed
into the peritoneum of non-Tg mice did not acquire athe peritoneal B cell populations in these mice has re-
Immunity
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Figure 5. Reconstitution of B-1 BCR Signal-
ing Phenotype Requires Coexpression of
CD5 and Lck
Murine CD5, Lyn, and Lck cDNAs (in conjunc-
tion with a bicistronic flourescent protein
marker) were retrovirally transduced individu-
ally or in tandem into K46 B lymphoma cells
to generate the following lines: CD5, Lck,
CD5/Lck, Lyn, and CD5/Lyn. All lympho-
mas were sorted by FACS for expression of
their respective fluorescent protein and com-
parable levels of surface IgM.
(A) Relative surface expression of IgM and
CD5 was determined for cell lines used in
biochemical analyses.
(B) All lines were examined for differences in
[Ca2]i mobilization following BCR aggrega-
tion. Shown is mean [Ca2]i concentration be-
fore and after stimulation.
(C) CH12, K46, and K46 variants were stim-
ulated for the times indicated with -IgM
F(ab)2 followed by cell lysis. Whole-cell ly-
sates (2 106 cell equiv.) and immunoprecipi-
tated lysates (20  106 cells) for CD5 and Lck
were resolved by SDS-PAGE and analyzed by
anti-phosphotyrosine immunoblotting. Blots
were then stripped and reprobed with anti-
effector Abs to determine absolute proteins
levels. Densitometry analysis was performed
on CD5 anti-phosphotyrosine and anti-CD5
immunoblots to establish relative ratio.
(D) CH12, CD5, and CD5/Lck cells were
gated for low and high expression levels of
surface CD5 followed by assessment of Ca2
mobilization following BCR aggregation. Data
shown are representative of those obtained
from multiple experiments.
hyporesponsive BCR phenotype, confirming the exis- 2-fold greater than their Lck-competent counterparts.
Other serum Ig isotypes did not appear affected by thetence of a B cell-autonomous role for Lck in B-1a cell
hyporesponsiveness. loss of Lck, although we cannot explain the high IgA
levels in the sera of 11/9 mice, which should produce
only transgene-encoded IgM, and we are currently in-Lck-Deficient Mice Have Enhanced Antibody-
Producing Cells and Serum Immunoglobulin vestigating the specificity and origin of these Igs. VH11
expression (RidA) in the circulating Ab repertoire corre-Isotypes of B-1 Origin
B-1 cells have long been known to be the primary source lated well with serum IgM levels in both 11/9 strains and
confirmed that the majority of circulating Ig producedof cells producing “natural antibodies” (NAb), primarily
of IgM and IgA isotypes (Hayakawa et al., 1984; Kawa- in these animals was encoded by the transgene (Kawa-
guchi, 1998).hara et al., 2003; Kroese et al., 1989). We assessed
whether alterations in the absolute numbers and/or re- Previously, it has been reported that upon activation,
peritoneal B-1 cells migrate to peripheral sites, such assponsiveness of the B-1 population due to deletion of
Lck are mirrored by changes in circulating NAb levels. secondary lymphoid organs, to become Ab-producing
cells (Kawahara et al., 2003; Kroese et al., 1989; Mura-Sera from unstimulated Lck-deficient 11/9 and non-Tg
mice and their Lck-competent counterparts was exam- kami et al., 1994; Ohdan et al., 2000; Watanabe et al.,
2000). Thus, the decrease in peritoneal B-1 cell numbersined by ELISA (Figure 7A). While total serum Ig was
modestly increased in Lck-deficient mice, these mice and increase in serum IgM (and IgA) in Lck-deficient
mice may be the result of heightened activation and/orhad titers for the isotypes IgM and IgA that were 2-
to 3-fold higher than non-Tg controls. Similarly, 11/9x differentiation of peritoneal B-1 cells. In support of this
idea, we observed a 2-fold increase in the number ofLck/ mice displayed IgM levels that were, on average,
Expression of Lck in B-1 Phenotype and Function
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Figure 6. Deletion of Lck Alters the Popula-
tion Dynamics and Responsiveness of Perito-
neal B-1 Cells
Peritoneal B cells from 11/9 and non-Tg mice
with or without Lck were examined for sur-
face phenotype and BCR responsiveness.
(A) Population of CD19 peritoneal cells fall-
ing into the B-1a phenotype (CD5  CD23;
dashed boxes).
(B) The absolute number of peritoneal CD19
B cells was assessed in control and Lck-defi-
cient mice (left). The percentage of B cells
falling onto the three major peritoneal subsets
(B-1a, B-1b, and B-2) was also determined
based on CD19, CD23, CD5, and CD11b
(right). Data shown in (A) and (B) are represen-
tative of at least three mice in each genotype.
(C) The change in [Ca2]i was measured fol-
lowing BCR stimulation on peritoneal B-1
(CD19/CD5/CD23) and B-2 (CD19/
CD5/CD23) populations from control, 11/9,
and Lck-deficient mice by FACS.
(D) Purified splenic B cells from 11/9 or
11/9xLck/ mice were labeled with fluores-
cent dye (CMFDA) and transferred to the peri-
toneal cavity of Lck/ or non-Tg mice, re-
spectively. 72 hr later, cells were recovered
by lavage and total cells gated for endoge-
nous B-2 (CD19/CD23/CD5), endogenous
B-1 (CD19/CD23/CD5), and transferred/
donor B cells (CD19/CMFDA). Gated popu-
lations were measured for differences in
[Ca2]i mobilization following BCR aggrega-
tion. These results are representative of those
obtained from three identical transfers.
IgM-producing cells in the spleens of Lck/ compared for B-1 cells, CD5 expression alone does not confer
hyporesponsiveness or “B-1-ness,” as demonstrated byto non-Tg mice (Figure 7B). This difference was even
more striking in Ab-producing cells (APC) isolated from the robust BCR-induced Ca2 mobilization in splenic
mesenteric lymph nodes (MLNs) of Lck/ mice, where CD5 B cells from 11/9 mice or their infrequent, albeit
almost a 5-fold increase was observed over controls naturally occurring, counterparts in wild-type mice. In-
(p  0.021). A similar pattern was observed in 11/9 Tg stead, we show that regulation of BCR signaling in peri-
mice deficient in Lck. While 11/9 mice had a comparable toneal B-1a cells requires coexpression of CD5 and Lck.
number of splenic Ab-producing cells as non-Tg mice, Our finding that Lck expression by splenic 11/9 B cells
there was an approximately 2.5-fold increase in APC is induced upon exposure to cell-free peritoneal super-
from spleens of 11/9xLck/ mice. Again, MLN isolates natant (known to be a source of the PtC Ag) supports
showed a greater difference as 11/9xLck/ mice had previous findings that acquisition of the B-1a hypore-
a 7-fold increase in APC over non-Tg mice and 3-fold sponsive phenotype is a consequence of Ag exposure
increase over Lck-competent 11/9 mice (p  0.015). and environment (Chumley et al., 2002). CD5 B-1 cells
These results suggest that differentiation and/or anti- genetically incapable of expressing Lck no longer dem-
body production by peritoneal B-1 cells may depend onstrate attenuated BCR signaling, and this phenotype
upon the regulatory effects of Lck expression. was shown to be an intrinsic effect of Lck ablation.
Lck-deficient mice displayed increased levels of Ab-
producing cells and serum Ig of isotypes characteristi-Discussion
cally produced by B-1 lineage cells. These findings are
indicative of enhanced B-1 cell activation and differenti-We have attempted to elucidate the mechanism(s) un-
ation in Lck/ mice. Together, our data support a modelderlying the altered state of BCR signaling in B-1 cells.
wherein B-1 cell hyporesponsiveness is acquired throughThe data presented here reveal a previously unrecog-
the de novo expression of two complementary regula-nized role for Lck in CD5 B-1a cell function, showing
tory elements, CD5 and Lck.that this kinase was essential for the unique BCR signal-
ing phenotype of B-1a cells. Though a classical marker In T cells, TCR aggregation leads to the tyrosine phos-
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ies have suggested that the src-kinase Lyn may also
phosphorylate CD5 (Ochi et al., 1999). Lyn is readily
detectable in both CD5 11/9 splenic B cells and CD5,
yet the degree of CD5-dependent inhibition in these
cells was modest. Perhaps more to the point, ectopic
expression of Lyn in conjunction with CD5 in K46 cells
did not result in a reduction in the BCR response. There-
fore, we contend that Lyn may phosphorylate CD5 and
thus may impart some effect on BCR signaling (i.e.,
diminished late-phase Ca2mobilization in splenic CD5
B cells). However, Lck expression is necessary for the
prototypical B-1a hyporesponsive phenotype. Possibly,
Lyn may not phosphorylate all CD5 sites required for
initiation of the regulatory pathway in B-1a cells (Gary-
Gouy et al., 2002; Vila et al., 2001). Densitometric analy-
sis confirmed a more efficient level of CD5 phosphoryla-
tion in the presence of Lck. Alternatively, expression of
Lck may serve a complementary inhibitory function not
related to CD5 phosphorylation, but acting at some
downstream point of convergence. We are currently in-
vestigating the molecular associations involving Lck and
CD5 in B-1 cells in an effort to understand these
pathways.
The absence of Lck in CD5 splenic B-1 cells from
11/9 and wild-type mice indicates that CD5 and Lck
expression is not coordinately regulated in B-1 cells.
Figure 7. Lck-Deficient Mice Show Alterations in Serum Antibody Available data support a model in which chronic low-
Levels that Correlate with Increased Ab-Producing Cell Formation level BCR stimulation, such as encounter with ubiqui-
(A) The basal titers for various immunoglobulin isotypes and VH11 tous self-Ag, is sufficient to induce CD5 expression, a
Abs (RidA) were measured by ELISA on sera collected from unimmu- phenomenon observed in vitro as well as in transgenic
nized non-Tg, 11/9, and their Lck-deficient cohorts. Dashed line mouse models of peripheral B cell anergy (Berland anddemarcates average value for end-point titrations of each sample
Wortis, 1998; Hippen et al., 2000; Wortis et al., 1995).set.
However, Lck expression appears to require additional(B) Total cells from spleen (top) or mesenteric lymph nodes (bottom)
of non-Tg, 11/9, Lck/, and 11/9xLck/ mice were isolated, ho- cues or signals provided, we propose, by environmental
mogenized, and subjected to ELIspot analysis for IgM-producing factors. One enticing hypothesis is that continued Ag
and VH11 antibody-producing cells. Shown is the average number exposure induces CD5 expression, regardless of locale,
(SD) of antibody-producing cells per 105 total cells. A two-tail but the peritoneum and pleural cavity provides a unique
Student’s t test was performed with statistical significance pre-
microenvironment in which prolonged residency causessumed for p values 0.05. Comparisons were made for selected
phenotypic changes, such as Lck expression. Thus, CD5data points: non-Tg versus Lck/ (*pspleen  0.034 and *pMLN  0.021)
and Lck coexpression would maintain BCR anergy ofand 11/9 versus 11/9xLck/ (**pspleen  0.065 and **pMLN  0.015).
At least three animals of each genotype were assayed by ELISA peritoneal B-1 cells, which carry potentially dangerous
and ELIspot and all samples were measured in triplicate. self-reactive specificities and are continually encoun-
tering their Ag. Conversely, exposure to this microenvi-
ronment in the absence of chronic BCR stimulation (or
phorylation of CD5 by the src-kinase Lck, and phospho- possibly dependent on some threshold affinity for self-
CD5 recruits key effector molecules that have been pos- Ag or exogenous Ag) may preclude CD5 expression,
tulated to mediate inhibitory signaling (Burgess et al., and these cells (namely, B-1b) would remain capable of
1992; Dennehy et al., 2001; Perez-Villar et al., 1999; Vila BCR-induced activation and/or differentiation. Tempo-
et al., 2001). CD5 can also associate with the BCR, and rary exposure to this microenvironment, such as in the
several studies have suggested that an analogous sig- case of transitory peritoneal B-2 cells, is insufficient to
naling cascade may prevent inappropriate activation of induce Lck (Chumley et al., 2002). Interestingly, while
self-reactive B-1 cells (Berland and Wortis, 2002; Bikah we find no evidence for CD5 or Lck upregulation in
et al., 1996). Our findings that both CD5 and Lck must peritoneal B-2 cells, they consistently show a weaker
be expressed in B cells for maximal inhibition of Ca2 response to BCR crosslinking compared to splenic B-2
mobilization supports this hypothesis. Further, we have cells, suggesting that the peritoneal microenvironment
found that CD5 and Lck can physically associate in may be generally suppressive (Figure 4 and data not
peritoneal B-1a cells (unpublished data). This is again shown).
similar to T cells, where CD5 not only associates with Evidence suggests that B-1 cell homing to specific
Lck following TCR ligation but also serves as a substrate body cavities, like omentum or peritoneum, may be criti-
for the kinase (Burgess et al., 1992; Dennehy et al., 2001). cal for natural Ab production and their role in innate
Seemingly inconsistent with this kinase-substrate rela- immunity (Ansel et al., 2002). However, few Ab-secreting
tionship is the finding that in both CD5 and splenic cells are actually found at these sites (Berland and
CD5 11/9 B cells, where Lck was not detectable, CD5 Wortis, 2002; Kroese et al., 1989). Instead, B-1 cell acti-
vation is followed by migration to peripheral lymphoidtyrosine phosphorylation was still observed. Prior stud-
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organs where they differentiate into Ab-forming cells. acquired differentiation state dependent on additional
Thus, while B-1 cells may encounter gut-associated Ags cues, such as microenvironment (Chumley et al., 2002).
and other factors in the peritoneal or pleural cavities, Once in place, the CD5/Lck inhibitory pathway regulates
differentiation is apparently prevented perhaps until BCR-mediated activation and differentiation, keeping
some appropriate second signal is received such as check on these potentially autoreactive cells. It will be
cytokines or T cell help. Recently, peritoneal CD5 B-1b interesting to examine the biological significance of
cells have been identified as likely precursors of periph- these mechanisms as they apply to the immune re-
eral NAb-producing cells (Kawahara et al., 2003; Ohdan sponse and tolerance, as well as development of pro-
et al., 2000; Watanabe et al., 2000). In our hands, Lck posed CD5 B cell malignancies, such as chronic
but CD5 peritoneal B-1b cells did not display the BCR lymphocytic leukemia (CLL) and marginal zone lympho-
anergy of their CD5 peritoneal partners. Similarly, BCR mas. Intriguingly, the lck gene has been found to lie in
aggregation-induced proliferation and Ca2mobilization a murine-SLE susceptibility locus derived from NZW
are increased in peritoneal B-1 cells from CD5-deficient mice (Vyse et al., 1996).
mice (Bikah et al., 1996). Interestingly, B-1 cell function
in CD5-deficient mice is reported “normal,” i.e., no ap- Experimental Procedures
parent decrease in NAbs levels. Here, we show that a
Mice, Cell Isolation, and Ex Vivo Culturingreciprocal depletion of Lck in CD5 peritoneal B-1a cells
VH11/V9 (,) Ig transgenic (11/9) mice, originally obtained fromalso restored BCR responsiveness and this coincided
R.R. Hardy (Fox Chase Cancer Center, Philadelphia, PA), were back-
with an increased frequency of Ab-producing cells in crossed for ten generations on the C57Bl/6 background. Nontrans-
these mice. Taken together, these data would support genic (non-Tg) littermate mice were used as controls. Lck-deficient
a model where CD5 and Lck coexpression are necessary mice were obtained from the Jackson Laboratory (Bar Harbor, ME)
as heterozygous mating pairs and bred to homozygosity. 11/9 Tgfor the maintenance of quiescence and possibly homeo-
mice deficient in Lck (11/9xLck/) were obtained through cross-stasis in the B-1 population; lack of either one of these
breeding. Expression of 11/9 Ig transgenes and disruption of themolecules may increase the potential for Ag-induced
lck gene was confirmed by PCR. Mice were housed and bred at theactivation and differentiation. One intriguing idea is that
NJMRC Biological Research facility and used at 8–12 weeks of age.
B-1a and B-1b cells represent a normal continuation of Splenic and peritoneal B cells were purified using an AutoMacs
differentiation within the peritoneal B-1 population. magnetic cell sorter (Miltenyi Biotec, Auburn, CA). Briefly, splenic
Lck has been observed in CD5 B cells from patients B cells were isolated by depleting total splenocytes of non-B cells
(Thy1.2, CD4, CD8, CD11b [Mac-1], CD11c, and Gr-1) usingwith chronic lymphocytic leukemia (CLL) and in perito-
appropriately conjugated magnetic beads. B cells were purified fromneal B-1 cells from mice and humans (Majolini et al.,
peritoneal lavage by removal of adherent cells and magnetic-bead1998). Recently, this same group has suggested that
depletion of non-B cells. The resultant population, which was
elevated BCR signaling in B-1 cells requires Lck (Ulivieri routinely 95% B cells, was subject to a further purification step if
et al., 2003). The authors hypothesized that Lck expres- B-1 cells were required. This was accomplished alternatively by
sion in B-1 cells helps achieve a higher basal activation magnetic-bead depletion of CD23 B-2 cells or positive selection
for CD5 B-1 cells. Culture of ex vivo cells in peritoneal lavagestate, required to overcome the intrinsic inhibitory mech-
supernatant was previously described (Chumley et al., 2002).anisms in place in these cells. Our data does not exclude
the possibility that Lck plays a positive role in B-1 BCR
Cell Lines, Retroviral Expression Constructs,signaling. Yet, while we observe similar changes in basal
and Transfectionssignaling in our Lck-deficient peritoneal CD5 B cells
The CH12 B cell lymphoma has been previously described(i.e., decreased phosphorylation and lowered basal
(Haughton et al., 1986). Characteristic of B-1 cells, receptor specific-
Ca2), these cells respond essentially like B-2 cells in ity of CH12 cells is broad with affinity to the hapten TMA and determi-
both BCR-mediated Ca2mobilization and protein phos- nants on bromelain-treated RBC. The K46 lymphoma was trans-
phorylation (Figure 6 and data not shown). Interestingly, fected with an IgM/1 BCR specific for nitrophenol (NP) yielding
K46 (Hombach et al., 1990). Cells were cultured in IMDM witha recent report by Rui et al. (2003) demonstrated that
5% heat-inactivated fetal calf serum (HyClone, Logan UT), 50 U/mlconstitutive Erk activity actually impedes B cell differen-
penicillin, and 50 U/ml streptomycin at 37C with 7.5% CO2.tiation mediated by Toll-like receptors. Thus, the in-
CD5, Lck, and Lyn cDNAs were cloned by PCR from a cDNAcreased Erk activity in B-1a cells, perhaps a direct “posi- library generated from whole splenocytes of C57Bl/6 mice. cDNA
tive” result of Lck expression, may be necessary for constructs were to facilitate directional cloning into retroviral ex-
maintaining tolerance; and the decreased basal Erk pression vectors. Pfu Polymerase (Stratagene, La Jolla, CA) was
phosphorylation in Lck-deficient B-1a cells, observed used to increase PCR fidelity and all constructs were sequenced
prior to use. The following PCR primers were used in this pro-by Ulivieri and us (data not shown), might imply a release
cess: 5 CD5 primer 5-CGGGATCCGCCACCATGGACCTCCCACGfrom this block. Such a model might predict Lck-defi-
AAG-3 and 3 CD5 primer 5-ATATGCGGCCGCTTACAGTCTGAGCcient peritoneal B-1 cells to be more susceptible to acti-
CAC-3, 5 Lck primer 5-CCACTCGAGGCCACCATGGGCTGTGTC
vation, migration, and differentiation, which would ex- TGC-3 and 3 Lck primer 5-AAGCGGCCGCTCAAGGCTGGGGCTG
plain the observed increase in the levels of circulating GTA-3, 5 Lyn primer 5-ACTCGAGGCCACCATGGGATGTATTAAA
natural Abs and Ab-producing cells in our Lck-deficient TCA-3 and 3 Lyn primer 5-AAGCGGCCGCCTACAATAGGCTTAGT
mice. Thus, Lck expression may have an additional in- CTCCATGC-3. The CD5 construct was cloned into the bicistronic
pMXI-EGFP retroviral vector (a kind gift of Dr. Gary Nolan, Stanfordhibitory role in B-1a cells, beyond its proposed interac-
University), allowing independent translation of EGFP and CD5. Sim-tion with CD5.
ilarly, the Lck and Lyn constructs were placed in the pMSCV-YFPWe have provided new evidence that CD5 expression
retroviral vector. Ecotropic Phoenix packaging cells (ATCC, Man-
alone is insufficient to demarcate B cells as B-1. Periph- assas, VA) were transfected with retroviral vector DNA using Effec-
eral B cells may express CD5 as a consequence of tene transfection system (QIAGEN Inc., Valencia, CA). Virus-con-
chronic contact with self-Ag or exogenous Ag. However, taining cell supernatants were used to infect cells. Cells were
analyzed and separated on a MoFlo cytometric sorter (DakoCytoma-Lck expression, and we would argue true B-1-ness, is an
Immunity
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tion, Ft. Collins, CO) for expression of EGFP, YFP, or both and for ELISA and ELIspot Assays
Sera were isolated from tail-bleeds of 3–4 mice for each strain be-the uniform expression of surface IgM. For the generation of cells
expressing both a EGFP and YFP retroviral construct, K46 cells tween 8 and 12 weeks of age. Polyclonal goat anti-mouse Ig (HL)
(Fisher) was used to coat 96-well ELISA plates. Duplicate serumstably infected with the pMXI-CD5-EGFP were sorted and then sub-
ject to a second infection with pMSCV-Lck-YFP or pMSCV-Lyn-YFP samples were serially diluted and incubated on ELISA plates. Bound
Abs were detected using horseradish peroxidase-conjugated goatfollowed by sorting, as described above.
anti-mouse Ig isotype specific Abs (Southern Biotech, Birmingham,
AL), and color development was achieved using (TMB, Pierce) sub-
Flow Cytometric Analysis strate buffer. The TMB reaction was stopped using 0.1 M H2SO4 and
Purified cells were resuspended and incubated with Fc-Block absorbance at 450 nm was measured. Shown is the sera dilution
(2.4G2). Samples were then incubated with optimal amounts of bio- beyond which no signal was detectable (end-point).
tinylated or directly fluorophore-conjugated antibodies. Monoclonal For ELIspot assay, total cells from the spleen or mesenteric lymph
antibodies directed against the following murine molecules were nodes of non-Tg (n  5), 11/9 (n  4), Lck/ (n  5), or 11/9xLck/
used: B220 (RA3-6B2; ATCC), CD23 (B3B4, BD Pharmingen, San (n  3) mice were isolated and the number of Ab-producing cells
Diego, CA), CD19 (1D3; BD Pharmingen), CD5 (53-7.313; BD Phar- per 105 total cells was determined. Briefly, sample cells were resus-
mingen), CD11b/Mac-1 (M1/70; BD Pharmingen), CD43 (S7; BD pended in media and incubated on goat anti-mouse Ig (HL) (South-
Pharmingen), IgM (b-7-6; a gift from Chris Huesser, Novartis, Swit- ern Biotech)-coated nitrocellulose membranes for 2 hr at 37C. Cells
zerland), IgD (JA12.5; ATTC), CD80 (16-10A1; BD Pharmingen), CD86 were lysed and membranes were washed with PBS/1% BSA/0.1%
(GL-1; BD Pharmingen), and RidA (anti-VH11 [Kawaguchi, 1998]; a Tween20. Membrane bound Abs were detected using alkaline phos-
gift from R.R. Hardy, Fox Chase, PA). Biotinylated antibodies were phatase-conjugated goat anti-mouse Ig isotype-specific Abs
visualized with streptavidin coupled to Tri Color, Phycoerythrin, Allo- (Southern Biotech). All samples were performed in triplicate. Two-
phycocyanin, or PE-Cy7 (Caltag, Burlingame, CA). Analysis was per- tail Student’s t tests were performed on selected data points to
formed on a FACSCalibur, BD-LSR (Becton Dickinson, San Jose, determine statistical significance (p values of  0.05 were consid-
CA) or CYAN (Dako/Cytomation). Forward and side scatter and/or ered to be in the 99% confidence interval).
7-AAD exclusion (Via-Probe, BD Pharmingen) were used to discrimi-
nate live cells. For intracellular staining, surface staining was per-
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